Home/Filings/4/0001243764-10-000003
4//SEC Filing

SCHMID HANS P 4

Accession 0001243764-10-000003

CIK 0000880771other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 6:40 PM ET

Size

17.1 KB

Accession

0001243764-10-000003

Insider Transaction Report

Form 4
Period: 2010-05-14
SCHMID HANS P
Pres & Mng Dir, SciClone Int'l
Transactions
  • Exercise/Conversion

    Common Stock

    2010-05-14$1.08/sh+35,000$37,80055,000 total
  • Sale

    Common Stock

    2010-05-14$3.84/sh55,000$211,2330 total
  • Exercise/Conversion

    Common Stock

    2010-05-14$1.81/sh+20,000$36,20020,000 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2010-05-1435,00090,000 total
    Exercise: $1.08Exp: 2019-03-06Common Stock (35,000 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2010-05-1420,00060,000 total
    Exercise: $1.81Exp: 2018-03-18Common Stock (20,000 underlying)
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.8 to $3.89 inclusive.
  • [F2]Granted under the Issuer's 2005 Equity Incentive Plan.
  • [F3]25% of such shares vest one year from the date of grant, of March 18, 2008, and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
  • [F4]25% of such shares vest one year from the date of grant, of March 6, 2009, and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.

Issuer

SCICLONE PHARMACEUTICALS INC

CIK 0000880771

Entity typeother

Related Parties

1
  • filerCIK 0001243764

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 6:40 PM ET
Size
17.1 KB